Author： Ertel S.I. Clozel J-P.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.5, 1997-05, pp. : 569-582
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Effects of mibefradil on uterine contractility
By Asokan K.T. Sarkar S.N. Mishra S.K. Raviprakash V.
European Journal of Pharmacology, Vol. 455, Iss. 1, 2002-11 ,pp. :
Clinical Pharmacokinetics of Mibefradil
By Welker H.A. Wiltshire H. Bullingham R.
Clinical Pharmacokinetics, Vol. 35, Iss. 6, 1998-12 ,pp. :
Inhibition of myogenic tone by mibefradil in rat cerebral arteries
By Lam E. Skarsgard P. Laher I.
European Journal of Pharmacology, Vol. 358, Iss. 2, 1998-10 ,pp. :
Diltiazem and mibefradil alter the pharmacokinetics of oral methylprednisolone
Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. :